Cancers, Vol. 16, Pages 339: The Magee 3 Equation Predicts Favorable Pathologic Response to Neoadjuvant Endocrine Therapy in Breast Cancer Patients
Conclusions: Patients with ME3 < 20 have a higher likelihood of presenting a pathological response, offering a cost-effective alternative tool to Oncotype DX. Larger future studies with a prospective design are awaited to confirm our findings.
Source: Cancers - Category: Cancer & Oncology Authors: Carlos Eduardo Paiva Maria Paola Montesso Zonta Rafaela Carvalho Granero Vitor Souza Guimar ães Layla Melo Pimenta Gustavo Ramos Teixeira Bianca Sakamoto Ribeiro Paiva Tags: Communication Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy | Health Management | HER2 | Hormones | Neoadjuvant Therapy | Study